On August 14, 2026, CG101 Injection, independently developed by Hangzhou Jiyuan Gene for the treatme

SYSU researchers confirmed YAP1-K90la lactylation triggers cisplatin resistance in bladder cancer, o

Recently, the research team led by Professor Lu Qianjin from the Institute of Dermatology, Chinese A

In April 2026, Mabwell (688062.SH) announced NMPA’s acceptance of its world’s first LILRB4/CD3-targe

Liver injury can deteriorate into acute liver failure, posing a severe threat to life. As an antimal

Fluoropharm will participate in the 24th CPHI China 2026, which will be held in Shanghai, China from

Ovarian cancer is known as the 'silent killer' due to the hidden nature of its early symptom

Recently, the FDA released a draft guidance titled 'Development of Non-Opioid Analgesics for the

Ifinatamab deruxtecan is a potentially first-in-class antibody-drug conjugate (ADC) targeting B7-H3,

Sodium fluorine [18F] injection is a positron emission tomography (PET) radioimaging agent used in b